Democrat · Former U.S. House · Kentucky, District 3
Latest filing Jan 18, 2018
Yes. John Yarmuth disclosed 2 purchases and 1 sale of Allergan (AGN) stock between Dec 1, 2015 and Dec 21, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Yes. John Yarmuth disclosed 2 purchases and 1 sale of Allergan (AGN) stock between Dec 1, 2015 and Dec 21, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
How big were John Yarmuth's Allergan trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $1K-$15K.
Did John Yarmuth make these Allergan trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does John Yarmuth still own Allergan stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did John Yarmuth report these trades?
The latest filing is dated Jan 18, 2018. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.
Reported trades and amount ranges, not what is held today. Reports can include a spouse and dependent children.
Loading